title: Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
abstract: Brook Baker describes the potential harms to global health from the Trans Pacific Partnership Agreement and its failure to balance the interests of patients and the public with those of industry.
authors.affiliation: Northeastern University School of Law, Program on Human Rights and the Global Economy, Boston, Massachusetts, United States of America.|University of KwaZulu Natal, Durban, South Africa.|Health Global Access Project, New York, New York, United States of America.
authors.forename: Brook K
authors.initials: BK
authors.lastname: Baker
mesh_terms: D001315:Australia; D002010:Brunei; D002170:Canada; D002677:Chile; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution*; D006297:Health Services Accessibility; D006801:Humans; D018973:Intellectual Property; D007391:International Cooperation / Q000331:legislation & jurisprudence*; D007449:Investments; D007564:Japan; D008296:Malaysia; D008800:Mexico; D009520:New Zealand; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D010568:Peru; D004364:Pharmaceutical Preparations / Q000191:economics / Q000600:supply & distribution; D012846:Singapore; D014481:United States; D014744:Vietnam
chemical_list: D016568:Drugs, Generic; D004364:Pharmaceutical Preparations